Staci Hestdalen, MD
Dermatology · Spokane Valley, WANPI 1194790006
Payments from drug & device makers
Across 258 payments — averaging $18.96 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1K
- Johnson & Johnson$882
- Lilly USA, LLC$658
- UCB, Inc.$289
- Galderma Laboratories, L.p.$228
- Pfizer$219
- plus $1K from 21 others
What the payments were for
- Food & beverage$4,71996%
- Education$1724%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 72 | $1,206 |
| Johnson & Johnson | 45 | $882 |
| Lilly USA, LLC | 35 | $658 |
| UCB, Inc. | 10 | $289 |
| Galderma Laboratories, L.p. | 13 | $228 |
| Pfizer | 13 | $219 |
| LEO Pharma Inc. | 10 | $193 |
| Novartis | 9 | $164 |
| Amgen | 8 | $162 |
| E.r. Squibb & Sons, L.L.C. | 9 | $144 |
| Merz North America, Inc. | 1 | $142 |
| Sun Pharmaceutical Industries Inc. | 5 | $114 |
| Regeneron Healthcare Solutions, Inc. | 4 | $80 |
| Sanofi | 4 | $61 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 3 | $51 |
| Almirall LLC | 2 | $50 |
| Organon | 2 | $30 |
| Dermavant Sciences, Inc. | 2 | $30 |
| Helsinn Therapeutics (U.S.), Inc. | 2 | $28 |
| Prugen, Inc. Pharmaceuticals | 2 | $25 |
| Verrica Pharmaceuticals Inc. | 1 | $25 |
| Lemaitre Vascular, Inc. | 1 | $22 |
| Genentech USA, Inc. | 1 | $22 |
| Bristol Myers Squibb | 1 | $21 |
| Strata Skin Sciences, Inc. | 1 | $18 |
| Incyte Corporation | 1 | $15 |
| DUSA Pharmaceuticals, Inc. | 1 | $12 |
How this compares
$4,891 in reported general payments places this provider in the 75th percentile of 323 dermatology providers in Washington.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Fluorouracil | 107 | $7,724 |
| Betamethasone Dipropionate | 93 | $3,797 |
| Clobetasol Propionate | 78 | $3,690 |
| Tacrolimus | 25 | $3,419 |
| Azelaic Acid | 23 | $2,687 |
| Metronidazole | 48 | $2,548 |
| Ketoconazole | 52 | $2,037 |
| Tretinoin | 25 | $1,902 |
| Doxycycline Hyclate | 41 | $1,494 |
| Minoxidil | 164 | $1,479 |
| ValacyclovirValacyclovir Hcl | 37 | $1,122 |
| Hydroxychloroquine Sulfate | 26 | $1,010 |
| Triamcinolone Acetonide | 50 | $1,005 |
| Finasteride | 135 | $953 |
| Imiquimod | 30 | $861 |
Paid to pharmacies, not to this prescriber.
Other dermatology in Spokane Valley
- Paul DunnSpokane Valley$28K
- Scott SmithSpokane Valley$9K
- William WerschlerSpokane$5.1M
- Clive LiuBellevue$3.3M
- Katherine ReedSpokane$3.1M
- Morrisa BaskinWenatchee$1.1M
- Vivian ShiSeattle$1.1M
- Daniel LevyBonney Lake$541K
- Daniel SugaiBellevue$302K
- Michi ShinoharaSeattle$277K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.